AVE 20.0% 0.3¢ avecho biotechnology limited

Ann: March 2024 Quarterly Activities Report & Appendix 4C, page-121

  1. 27,728 Posts.
    lightbulb Created with Sketch. 1327
    Astute operators considering the trial costs but also maintaining integrity by having strict inclusion criteria

    By effectively receiving our tax refund immediately, the Company can spend these funds on the Phase III trial, deferring the need for additional dilutive equity raising..........CLEVER!

    Patience will be the key IMO
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.001(20.0%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $135 45K

Buyers (Bids)

No. Vol. Price($)
51 92218918 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 76402411 24
View Market Depth
Last trade - 16.10pm 05/09/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.